Advertisement
Journal Home
Search for

Volume 194, Issue 3, Pages 815-820 (March 2006)


View previous. 39 of 64 View next.

Acupressure for the in-patient treatment of nausea and vomiting in early pregnancy: A randomized control trial

Alexander Heazell, MBChB(Hons)aCorresponding Author Informationemail address, Joy Thorneycroft, MBChBb, Victoria Walton, MBChBc, Ian Etherington, MDd

Received 26 April 2005; received in revised form 21 July 2005; accepted 18 August 2005.

Objective

The purpose of this study was to evaluate the efficacy of acupressure at the P6 point for the in-patient treatment of severe nausea and vomiting in early pregnancy.

Study design

This was a prospective single-blind randomized control trial that involved 80 patients with nausea and vomiting plus ketonuria before 14 weeks of gestation.

Results

There was no difference between length of stay, amount of medication, or fluid required between the acupressure and placebo groups, although acupressure reduced the number of patients who stayed ≥4 nights in the hospital. Acupressure was well tolerated and not associated with an increase in perinatal morbidity or death.

Conclusion

The use of acupressure at the P6 point does not reduce the amount of antiemetic medication that is required, the requirement for intravenous fluid, and median duration of in-patient stay more than the use of placebo. A small reduction was seen in the number of women who required ≥4 days in the hospital.

a Maternal and Fetal Health Research Centre, St. Mary's Hospital, Manchester, UK

b The Hawthorns Surgery, West Midlands, UK

c Springfield Medical Practice, Springfield, Birmingham, UK

d Rockhampton Hospital, University of Queensland, Rockhampton, Australia

Corresponding Author InformationReprint requests: Alexander Heazell, MBChB(Hons), Department of Obstetrics and Gynaecology, Maternal and Fetal Health Research Centre, St. Mary's Hospital, Whitworth Park, Manchester M13 0JH, UK.

PII: S0002-9378(05)01365-7

doi:10.1016/j.ajog.2005.08.042


View previous. 39 of 64 View next.

Advertisement